CA039771/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	1
2005	1
2007	1
2008	4
2012	3
2013	1
2014	4
2015	3
2016	2
2017	1
2024	0

1

Retinoblastoma and Neuroblastoma Predisposition and Surveillance.

Kamihara J, Bourdeaut F, Foulkes WD, Molenaar JJ, Mossé YP, Nakagawara A, Parareda A, Scollon SR, Schneider KW, Skalet AH, States LJ, Walsh MF, Diller LR, Brodeur GM. Kamihara J, et al. Clin Cancer Res. 2017 Jul 1;23(13):e98-e106. doi: 10.1158/1078-0432.CCR-17-0652. Clin Cancer Res. 2017. PMID: 28674118 Free PMC article. Review.

2

Mechanisms of neuroblastoma regression.

Brodeur GM, Bagatell R. Brodeur GM, et al. Nat Rev Clin Oncol. 2014 Dec;11(12):704-13. doi: 10.1038/nrclinonc.2014.168. Epub 2014 Oct 21. Nat Rev Clin Oncol. 2014. PMID: 25331179 Free PMC article. Review.

3

Therapeutic targets for neuroblastomas.

Brodeur GM, Iyer R, Croucher JL, Zhuang T, Higashi M, Kolla V. Brodeur GM, et al. Expert Opin Ther Targets. 2014 Mar;18(3):277-92. doi: 10.1517/14728222.2014.867946. Epub 2014 Jan 6. Expert Opin Ther Targets. 2014. PMID: 24387342 Free PMC article. Review.

4

CHD5 is required for spermiogenesis and chromatin condensation.

Zhuang T, Hess RA, Kolla V, Higashi M, Raabe TD, Brodeur GM. Zhuang T, et al. Mech Dev. 2014 Feb;131:35-46. doi: 10.1016/j.mod.2013.10.005. Epub 2013 Nov 16. Mech Dev. 2014. PMID: 24252660 Free PMC article.

5

A three-gene expression signature model for risk stratification of patients with neuroblastoma.

Garcia I, Mayol G, Ríos J, Domenech G, Cheung NK, Oberthuer A, Fischer M, Maris JM, Brodeur GM, Hero B, Rodríguez E, Suñol M, Galvan P, de Torres C, Mora J, Lavarino C. Garcia I, et al. Clin Cancer Res. 2012 Apr 1;18(7):2012-23. doi: 10.1158/1078-0432.CCR-11-2483. Epub 2012 Feb 10. Clin Cancer Res. 2012. PMID: 22328561 Free PMC article.

6

Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.

Naraparaju K, Kolla V, Zhuang T, Higashi M, Iyer R, Kolla S, Okawa ER, Blobel GA, Brodeur GM. Naraparaju K, et al. Oncotarget. 2016 Mar 29;7(13):15977-85. doi: 10.18632/oncotarget.7434. Oncotarget. 2016. PMID: 26895110 Free PMC article.

7

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.

Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM, Maris JM. Cole KA, et al. Mol Cancer Res. 2008 May;6(5):735-42. doi: 10.1158/1541-7786.MCR-07-2102. Mol Cancer Res. 2008. PMID: 18505919 Free PMC article.

8

Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.

Kong XT, Valentine VA, Rowe ST, Valentine MB, Ragsdale ST, Jones BG, Wilkinson DA, Brodeur GM, Cohn SL, Look AT. Kong XT, et al. Neoplasia. 1999 Apr;1(1):80-9. doi: 10.1038/sj.neo.7900010. Neoplasia. 1999. PMID: 10935473 Free PMC article.

9

Role of CHD5 in human cancers: 10 years later.

Kolla V, Zhuang T, Higashi M, Naraparaju K, Brodeur GM. Kolla V, et al. Cancer Res. 2014 Feb 1;74(3):652-8. doi: 10.1158/0008-5472.CAN-13-3056. Epub 2014 Jan 13. Cancer Res. 2014. PMID: 24419087 Free PMC article. Review.

10

Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.

Higashi M, Kolla V, Iyer R, Naraparaju K, Zhuang T, Kolla S, Brodeur GM. Higashi M, et al. Mol Cancer. 2015 Aug 7;14:150. doi: 10.1186/s12943-015-0425-y. Mol Cancer. 2015. PMID: 26245651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year